2025 fourth_quarter Filing
RRFiled
November 20, 2025
Lobbying Activities
PharmacyView all
Lobbying for the breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.
VeteransView all
Lobbying for the breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.
Lobbyists (7)
SUSAN HIRSCHMANN
Newms MELINDA M MAXFIELD
NewLAURA M SIMMONS
Advisor, Office of Legislative Affairs, Dept of Homeland Security
NewForeign Entities
NOVOCURE LIMITED (OWNS 100% OF NOVOCURE LUXEMBOURG)
JE0Ownership: 100%
NOVOCURE GMBH
CH0Ownership: 100%
NOVOCURE LUXEMBOURG S.A.R.L. (OWNS 100% OF NOVOCURE GMBH)
LU0Ownership: 100%